Dual pulmonary infection with Candida dubliniensis and Aspergillus fumigatus in a child with chronic granulomatous disease

Journal of Infection

Volumn 50, Issue 1, 2005, Pages 72-75

  Miron, Dan ^a   Horowitz, Yoseph ^a   Lumelsky, Dimitry ^a   Hanania, Shay ^a   Colodner, Raul ^a,b  

^a HAEMEK MEDICAL CENTER   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; CEFUROXIME; COTRIMOXAZOLE; FLUCONAZOLE; ITRACONAZOLE;

ANTIBIOTIC SENSITIVITY; ARTICLE; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; BRONCHOSCOPY; CANDIDA DUBLINIENSIS; CANDIDIASIS; CASE REPORT; CHRONIC GRANULOMATOUS DISEASE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; LUNG INFECTION; LUNG INFILTRATE; LUNG LAVAGE; LUNG NODULE; MINIMUM INHIBITORY CONCENTRATION; PRESCHOOL CHILD; SPUTUM ANALYSIS; THORAX RADIOGRAPHY;

ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; BRONCHOALVEOLAR LAVAGE FLUID; CANDIDA; CANDIDIASIS; CHILD; FEMALE; GRANULOMATOUS DISEASE, CHRONIC; HUMANS; LUNG DISEASES, FUNGAL;

EID: 11144309015     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2004.05.017     Document Type: Article

References (15)

1. Sullivan D.J. Westerneng T.J. Haynes K.A. Bennet D.E. Coleman D.C. Candida dubliniensis sp. Nov.: Phenotypic and molecular characterization of a novel species associated with oral candidiasis in HIV-infected individuals Microbiology 141 1995 1507-1521
2. Pinjon E. Sullivan D. Salkin I. Shanley D. Coleman D. Simple, inexpensive, reliable method for differentiation of Candida dubliniensis from Candida albicans J Clin Microbiol 36 1998 2093-2095
3. Polacheck I. Strahilevitz J. Sullivan D. Donnelly S. Salkin I.F. Coleman D. Recovery of Candida dubliniensis from non-human immunodeficiency virus-infected patients in Israel J Clin Microbiol 38 2000 170-174
4. Schorling S.R. Kortinga H.C. Froschb M. Muhlschlegel F.A. The role of Candida dubliniensis in oral candidiasis in human immunodeficiency virus-infected individuals Crit Rev Microbiol 26 2000 59-68
5. Brandt M.E. Harrison L.H. Pass M. Sofair A.N. Sharon H. et al. Candida dubliniensis Fungemia: The first four cases in North America Emerg Infect Dis 6 2000 46-49
6. Vilela M.M. Kamei K. Sano A. Tanaka R. Uno J. Takahashi I. Ito J. Yarita K. Miyaji M. Pathogenicity and virulence of Candida dubliniensis: Comparison with C. albicans Med Mycol 40 2002 249-257
7. Brown D.M. Jabra-Rizk M.A. Falkler W.A. Baqui A.A. Meiller T.F. Identification of Candida dubliniensis in a study of HIV-seropositive pediatric dental patients Pediatr Dent 22 2000 234-238
8. Meis J.F. Ruhnke M. De Pauw B.E. Odds F.C. Siegert W. Verweij P.E. Candida dubliniensis candidemia in patients with chemotherapy-induced neutropenia and bone marrow transplantation Emerg Infect Dis 5 1999 150-153
9. Sebti A. Kiehn T.E. Perlin D. Chaturverdi V. Wong M. Doney A. Park A. Sepkowitz K.A. Candida dubliniensis at a cancer center Clin Infect Dis 32 2001 1034-1038
10. Odds F.C. Vn Nuffel I. Dams G. Prevalence of Candida dubliniensis isolates in a yeast stock collection J Clin Microbiol 36 1998 2869-2873
11. Moran G.P. Sullivan D.J. Henman M.C. McCreary C.E. Harington B.J. Shanley D.B. Coleman D.C. Antifungal drug susceptibilities of oral Candida dubliniensis isolates from human immunodeficiency virus (HIV)-infected and non-infected subjects and generation of stable fluconazole-resistant derivatives in vitro J Antimicrob Agents Chemother 41 1997 617-623
12. Qidos G. Carrilo-Munoz A.J. Arevalo M.P. Slgado J. Alonso-Vargas R. In vitro susceptibility of Candida dubliniensis to current and new antifungal agents Chemotherapy 46 2000 395-401
13. Melanie W.M. Gigliotti F. Update on antifungal agents Pediatr Inf Dis J 20 2001 993-995
14. Sallmann S. Heilmann A. Heinke F. Kerkmann M.L. Schuppler M. Hahn G. Gahr M. Rosen-Wolff A. Roesler J. Capofungin therapy for Aspergillus lung infection in a boy with chronic granulomatous disease Pediatr Infect Dis J 22 2003 199-200
15. Elanjikal Z. Sorensen J. Schmidt J. Dupuis W. Tintelnot K. Jautzke G. Lingebiel T. Lehrnbecher T. Combination therapy with caspofungin and liposomal amphitericin B for invasive aspergillosis Pediatr Infect Dis J 22 2003 653-656